Fund moves
74 tracked managers disclosed the same change for Q1 2026. From a 13F filed Jun 9, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded May 18, 2026 · Filed May 19, 2026
CME's Sr MD & Chief HR Officer sold $1.75M of CME shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$1,752,536
Shares × reported transaction price
26 days after results of Apr 22, 2026, 65 days before results of Jul 22, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $305.12 on May 18, 2026, 18% above its 52-week low and 7% below its high, after a 1% drop over the previous 30 trading days
52-week range $258.83 (Sep 15, 2025) to $326.46 (Mar 2, 2026), 68% of the way up, from 251 adjusted closes. 30 trading days earlier: $308.57 on Apr 6, 2026. Describes the past only, not a forecast
RSI 65, 8% above its 200-day average, 3% above its 50-day average, 7% below the 52-week high, 20-day volatility 20% a year, against the S&P 500: +2 points over 1 month, −8 points over 3 months, −2 points over 6 months
From the adjusted closes up to May 18, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Hilda Harris Piell's largest sale of CME in their filings since 2007
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
A securities lawsuit naming the company as a defendant was filed on Jun 14, 2024 in the U.S. District Court, S.D. New York. A filing is an allegation, not a finding.
Global Carbon Opportunity (Cayman) Fund Ltd. v. CME Group Inc., docket 1:24-cv-04562, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.8% | +1.2% | −5.0% |
| 30 days | −15.5% | +0.4% | −15.9% |
| 90 days | −6.4% | +3.5% | −9.9% |
| 180 days | +10.1% | −0.2% | +10.3% |
Past results only. Not a forecast.
Fund moves
74 tracked managers disclosed the same change for Q1 2026. From a 13F filed Jun 9, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
74 tracked managers disclosed the same change for Q1 2026. From a 13F filed May 22, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Insider selling
Traded May 15 · filed 3 days laterNot reported under a pre-arranged trading plan
The CEO of CME sold $7.75M of CME shares. The filing does not indicate a pre-arranged trading plan.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.